Irccs Istituto Europeo Di Oncologia (IEO); Emato-Oncologia

Milan, Lombardy 20141

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Lymphoma

Studies at this site

• A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma — Completed
• A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) — Stopped early